Boston Properties Doubles Down On Life Sciences With $100M Waltham Buy

The nation’s largest publicly traded office landlord is doubling down on life sciences in one of Boston’s hottest suburbs for commercial development.

Google Maps
The Sanofi Genzyme Campus Along Second Ave. In Waltham.

Boston Properties purchased 153 and 211 Second Ave. for $100M in cash from Montana Avenue Capital Partners, the REIT announced late last week. The two lab properties total 153K SF and are fully leased to biopharmaceutical giant Sanofi Genzyme. The properties sit near two other Boston Properties life sciences properties and add to the company’s portfolio of nearly 5M SF of office and lab space in the Waltham/Lexington region.

“Waltham continues to be a dominant urban edge location for life sciences organizations that want to attract and retain highly-educated talent,” Boston Properties Executive Vice President Bryan Koop said in a statement.

Montana Avenue Managing Partner Jeremy Rogers declined to comment Monday. The Los Angeles-based developer purchased the Second Avenue portfolio from Sanofi Genzyme in 2019 for $68.5M, Middlesex County land records show. The private firm owns a portfolio across California, Boston and Austin, Texas.

Boston Properties has ramped up life sciences investments, especially in Greater Boston and South San Francisco, catching onto the industry that shows no signs of slowing. The company has more than 3M SF leased to life sciences tenants, 2M SF of office-to-lab conversions and 4M SF of ground-up development across Cambridge, Waltham and South San Francisco, CEO Owen Thomas said in April during the firm's Q1 2021 earnings call.

Other projects by Boston Properties in Waltham include 180 City Point, a 330K SF ground-up development, 880 Winter St., a 224K SF office-to-lab conversion and 751 Gateway, a 229K SF ground-up lab development. Boston Properties claims the labs total 920K SF and $650M of its current development investments.

The suburb has matured as a commercial cluster and alternative for tenants compared to the pricier Boston and Cambridge markets. The Lexington and Waltham region has approximately 3.7M SF of lab space with rents ranging from $50 to $70 per SF, according to a 2020 Newmark report.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Revolution Medicines Nearing Agreement For 700K SF Lease In Redwood City

Alexandria Sells Cambridge Lab Condo Units For $45M

Developers Line Up To Convert Boston Offices To Housing, But Most Still Stuck At Starting Gate

Oncology Company Expands Footprint At Hines' Life Sciences Campus

State's High Court Allows $325M Boston Soccer Stadium Project To Proceed

Oxford Properties Pays $435M For Boston Office Tower, Eyes More Deals

AvalonBay, Equity Residential Selling Boston Towers As Part Of Merger Settlement

Suburban Industrial Campus Trades For $47M: The Boston Deal Sheet

Millennium Partners Lands $281M Loan For Winthrop Center Tower

Lightstone Group Acquires Amazon Robotics Building For $43M

'Not In The Business Of Losing Our Customers': Renewals Dominate Boston Office Market

UK Investment Giant Funds First U.S. Development In Boston Suburb